IP Library Granted Patent US 8,871,707
Granted Patent B2
US 8,871,707 · App. 12/884,116 · Granted Oct 28, 2014

Elastin producing fibroblast formulations and methods of using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,871,707
App. No.
12/884,116
Granted
Oct 28, 2014
Kind
B2
Abstract

The present invention describes therapeutic compositions comprising fibroblasts that have been stimulated to increase expression of extracellular matrix components or elastin, or to produce enhanced elastogenesis or the appearance thereof at a site of administration. The therapeutic fibroblast formulations can be prepared using a variety of elastogenic agents, including digests of mammalian elastin, chemically digested plant extracts comprising elastin-like peptides, and synthetic elastogenic peptides. The invention further comprises cosmetic and pharmaceutical treatment methods using the therapeutic fibroblast compositions of the invention.

Claims (15)

1. A method for improving appearance or elasticity of a tissue comprising: administering to a mammal in need thereof an effective amount of a composition comprising a population of cultured dermal fibroblasts, wherein said population of cultured dermal fibroblasts is pretreated with an elastin peptide fragment, wherein said elastin peptide fragment consists of a peptide having a sequence selected from the group consisting of PGGVLPG (SEQ ID NO: 47), VGVVPG (SEQ ID NO: 48), IGLGPGGV (SEQ ID NO: 49), VGAMPG (SEQ ID NO: 51), VGLSPG (SEQ ID NO: 52), IGAMPG (SEQ ID NO: 54), IGVAPG (SEQ ID NO: 55), IGLSPG (SEQ ID NO: 56), VGAMPGAAAAAVGAMPG (SEQ ID NO: 58), VGLSPGAAAAAVGLSPG (SEQ ID NO: 59), VGVAPGAAAAAVGVAPG (SEQ ID NO: 60) IGAMPGAAAAAIGAMPG (SEQ ID NO: 61), IGVAPGAAAAAIGVAPG (SEQ ID NO: 62), IGLSPGAAAAAIGLSPG (SEQ ID NO: 63), GXXPG (SEQ ID NO: 2), and a combination thereof.

2. The method of claim 1 wherein said elastin peptide fragment consists of a peptide having a sequence GXXPG (SEQ ID NO: 2), wherein X represents any of the natural amino acids.

3. The method of claim 1 wherein said elastin peptide fragment consists of a peptide having a sequence PGGVLPG (SEQ ID NO: 47), VGVVPG (SEQ ID NO: 48), or IGLGPGGV (SEQ ID NO: 49).

4. The method of claim 1 , wherein said elastin peptide fragment consists of a peptide having a sequence VGAMPG (SEQ ID NO: 51), VGLSPG (SEQ ID NO: 52), IGAMPG (SEQ ID NO: 54), IGVAPG (SEQ ID NO: 55), IGLSPG (SEQ ID NO: 56), VGAMPGAAAAAVGAMPG (SEQ ID NO: 58), VGLSPGAAAAAVGLSPG (SEQ ID NO: 59), VGVAPGAAAAAVGVAPG (SEQ ID NO: 60) IGAMPGAAAAAIGAMPG (SEQ ID NO: 61), IGLSPGAAAAAIGLSPG (SEQ ID NO: 63), or IGVAPGAAAAAIGVAPG (SEQ ID NO: 62).

5. The method of claim 1 wherein said elastin peptide fragment is obtained or derived from a plant.

6. The method of claim 1 wherein said elastin peptide fragment is obtained or derived from rice bran.

7. The method of claim 1 , wherein said composition is administered by injection.

8. The method of claim 1 , wherein said composition stimulates elastogenesis at the site of administration.

9. The method of claim 1 , wherein said composition improves the appearance of visible lines or wrinkles.

10. The method of claim 1 , wherein said composition improves the appearance of scar tissue.

11. A method for stimulating new blood vessel formation in a tissue comprising: administering to a mammal in need thereof an effective amount of a composition comprising a population of cultured dermal fibroblasts, wherein said population of cultured dermal fibroblasts is pretreated with an elastin peptide fragment, wherein said elastin peptide fragment consists of a peptide having a sequence selected from the group consisting of PGGVLPG (SEQ ID NO: 47), VGVVPG (SEQ ID NO: 48), IGLGPGGV (SEQ ID NO: 49), VGAMPG (SEQ ID NO: 51), VGLSPG (SEQ ID NO: 52), IGAMPG (SEQ ID NO: 54), IGVAPG (SEQ ID NO: 55), IGLSPG (SEQ ID NO: 56), VGAMPGAAAAAVGAMPG (SEQ ID NO: 58), VGLSPGAAAAAVGLSPG (SEQ ID NO: 59), VGVAPGAAAAAVGVAPG (SEQ ID NO: 60) IGAMPGAAAAAIGAMPG (SEQ ID NO: 61), IGVAPGAAAAAIGVAPG (SEQ ID NO: 62), IGLSPGAAAAAIGLSPG (SEQ ID NO: 63), GXXPG (SEQ ID NO: 2), and combination thereof.

12. The method of claim 11 wherein said administration is by injection.

13. The method of claim 11 wherein said administration is performed in preparation for plastic surgery.

14. The method of claim 1 wherein said elastin peptide fragment consists of a peptide having a sequence GXXPG (SEQ ID NO: 2), wherein X represents any of the natural amino acids, 3-hydroxyproline, 4-hydroxyproline, or a therapeutically acceptable acid addition salt thereof.

15. The method of claim 1 wherein the composition further comprises an additive selected from a manganese compound, a manganese salt, MnCl 2 , MnSO 4 , MnPCA, a trivalent iron compound, ferric ammonium citrate, sodium, an activator of lysyl oxidase, copper, copper peptides, tretinoin, vitamin E, zinc, retinol, an amino acid, tropoelastin, compounds, transforming growth factor beta-1, hyaluronic acid, epitopes for extracellular matrix proteins, cytokines, growth factors, desmosine, fibrillin, MAGP 1, LTBP2, versican, collagen, fibronectin, EBP, PDGF, bFGF, FGF, IL-1B, an anti-inflammatory agent, a sunscreen, a sunblock, a stimulator of protein synthesis, a cell membrane stabilizing agent, carnitine, a moisturizing agent, a coloring agent, an opacifying agent, aloe vera, an antioxidant, azulene, beeswax, benzoic acid, beta-carotene, butyl stearate, camphor, caster oil, chamomile, cinnamate, clay, cocoa butter, coconut oil, cucumber, dihydroxyacetone, elastin, estrogen, ginseng, glutamic acid, glycerin, glycolic acid, a humectant, hydroquinone, lanolin, lemon, a liposome, mineral oil, monobenzone, a nucleic acid, oatmeal, paba, panthenol, petroleum jelly, propylene glycol, royal jelly, seaweed, silica, sodium lauryl sulfate sulfur, witch hazel, zinc, zinc oxide, shea butter, and a combination thereof.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2024
From: ELASTOGENESIS LLC
To: NULASTIN, INC.
Reel/Frame 068190/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2024
From: THE HOSPITAL FOR SICK CHILDREN
To: ELASTOGENESIS LLC
Reel/Frame 067829/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2019
From: HUMAN MATRIX SCIENCES, LLC
To: ELASTOGENESIS, LLC
Reel/Frame 048891/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2010
From: MITTS, THOMAS; JIMENEZ, FELIPE
To: HUMAN MATRIX SCIENCES, LLC
Reel/Frame 025001/0865 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2010
From: HINEK, ALEKSANDER
To: THE HOSPITAL FOR SICK CHILDREN
Reel/Frame 025001/0870 →